First report of solitary cavitation nodules in the lungs with Mycobacterium canariasense

Jing Liu; Meiying Wu; Jianping Zhang; Cuilin Shi

doi:10.3855/jidc.18535

First report of solitary cavitation nodules in the lungs with Mycobacterium canariasense

Authors

Jing Liu The Affiliated Infectious Diseases Hospital of Soochow University, The Fifth People's Hospital of Suzhou, Suzhou 215000, Jiangsu, China https://orcid.org/0000-0001-7103-1160
Meiying Wu The Affiliated Infectious Diseases Hospital of Soochow University, The Fifth People's Hospital of Suzhou, Suzhou 215000, Jiangsu, China
Jianping Zhang The Affiliated Infectious Diseases Hospital of Soochow University, The Fifth People's Hospital of Suzhou, Suzhou 215000, Jiangsu, China
Cuilin Shi The Affiliated Infectious Diseases Hospital of Soochow University, The Fifth People's Hospital of Suzhou, Suzhou 215000, Jiangsu, China https://orcid.org/0000-0002-9394-7177

DOI:

https://doi.org/10.3855/jidc.18535

Keywords:

Canariasense, solitary cavitation nodules, mNGS

Abstract

Introduction: Mycobacterium canariasense is a relatively rare and rapidly growing nontuberculous mycobacterium (NTM) infection.

Case report: This case report describes a 36-year-old man with a Canariasense infection in the lung with solitary cavitation nodules located subpleural on CT scan, for which the final diagnosis was made by metagenomic next-generation sequencing (mNGS) of bronchoalveolar lavage fluid (BALF-mNGS). It was successfully treated with levofloxacin and amikacin.

Conclusions: This experience is instructive because clinical diagnostic and CT imaging characteristics and treatment strategy guidelines for pulmonary infections caused by M. canariasense have not yet been established.

Downloads

Published

2024-05-30

How to Cite

Liu J, Wu M, Zhang J, Shi C (2024) First report of solitary cavitation nodules in the lungs with Mycobacterium canariasense. J Infect Dev Ctries 18:826–828. doi: 10.3855/jidc.18535

Download Citation

Endnote/Zotero/Mendeley (RIS)

Issue

Vol. 18 No. 05: May 2024

Section

Case Reports

License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).